Pandemblock Ltd

Pandemblock is a Finnish biotechnology company dedicated to developing innovative antiviral intranasal inhibitors for better pandemic preparedness and prevention. Our nasal spray product candidates are based on the proprietary Sherpabody-platform, facilitating Pandemblock's mission to revolutionize mucosal protection against entire viral families to prevent future pandemics. We are working determinedly to advance our first product Covidin, an intranasal prophylactic and early therapeutic candidate against SARS-CoV-2, into the clinic.